Regulatory natural autoantibodies to apoptotic cells: Pallbearers and protectors

Arthritis and Rheumatism

Volumn 63, Issue 3, 2011, Pages 597-602

  Silverman, Gregg J ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD103 ANTIGEN; COLLAGEN TYPE 2; COMPLEMENT COMPONENT C1Q; FC RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M T 15 ANTIBODY; INTERLEUKIN 12P70; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE BINDING LECTIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; AUTOIMMUNE DISEASE; BIRTH; CELL MEMBRANE; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE REARRANGEMENT; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; JOINT SWELLING; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NOTE; PHAGOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

APOPTOSIS; AUTOANTIBODIES; HUMANS; PHAGOCYTES; RHEUMATIC DISEASES;

EID: 79953715358     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30140     Document Type: Note

References (26)

1. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004;22:431-56. (Pubitemid 38680429)
2. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007;171:2-8. (Pubitemid 47339220)
3. Silverman GJ, Gronwall C, Vas J, Chen Y. Natural autoantibodies to apoptotic cell membranes regulate fundamental innate immune functions and suppress inflammation. Discov Med 2009;8:151-6.
4. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995;7:812-8. (Pubitemid 26038522)
5. Binder CJ, Silverman GJ. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol 2005;26: 385-404. (Pubitemid 40468892)
6. Shaw PX, Goodyear CS, Chang MK, Witztum J, Silverman GJ. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis- associated neo-antigens and apoptotic cells. J Immunol 2003;170:6151-7. (Pubitemid 36682598)
7. Binder C, Horkko S, Dewan A, Chang MK, Kieu E, Goodyear C, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between oxidized LDL and Streptococcus pneumoniae. Nat Med 2003;9:736-43. (Pubitemid 36749223)
8. Reardon CA, Miller ER, Blachowicz L, Lukens J, Binder CJ, Witztum JL, et al. Autoantibodies to oxLDL fail to alter clearance of injected oxLDL in apolipoprotein E deficient mice. J Lipid Res 2004;45:1347-54. (Pubitemid 38802638)
9. Chen Y, Khanna S, Goodyear CS, Park YB, Raz E, Thiel S, et al. Regulation of dendritic cells and macrophages by an antiapoptotic cell natural antibody that enhances phagocytic clearance, suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 2009;183:1346-59.
10. Chen Y, Park YB, Patel E, Silverman GJ. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 2009;182: 6031-43.
11. Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000;105:1731-40. (Pubitemid 30421754)
12. Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, Friedman P, et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad SciUSA 1999;96:6353-8. (Pubitemid 29256669)
13. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001;194: 781-95. (Pubitemid 32983014)
14. Nauta AJ, Castellano G, Xu W, Woltman AM, Borrias MC, Daha MR, et al. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol 2004;173: 3044-50. (Pubitemid 39142010)
15. Bohlson SS, Fraser DA, Tenner AJ. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 2007; 44:33-43. (Pubitemid 44647109)
16. Quartier P, Potter PK, Ehrenstein MR, Walport MJ, Botto M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol 2005;35:252-60. (Pubitemid 40123872)
17. Ogden CA, Kowalewski R, Peng Y, Montenegro V, Elkon KB. IgM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 2005;38:259-64. (Pubitemid 40974955)
18. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711. (Pubitemid 37174545)
19. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998;188:1359-68. (Pubitemid 28478024)
20. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macro-phages. J Exp Med 1998;188:2313-20. (Pubitemid 29028503)
21. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006;6:823-35. (Pubitemid 44631651)
22. Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004;199:1631-40. (Pubitemid 38821996)
23. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L. Fcγ RIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-a production induced by apoptotic cells combined with lupus IgG. J Immunol 2003;171:3296-302. (Pubitemid 37093557)
24. Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegard J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology (Oxford) 2008;47: 1144-50. (Pubitemid 352038217)
25. Silverman GJ, Germar K, Goodyear CS, Andrews KA, Ginzler EM, Tsao BP. Genetic imprinting of autoantibody repertoires in SLE patients. Clin Exp Immunol 2008;153:102-16. (Pubitemid 351809346)
26. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009;119:1335-49.